logo
Share SHARE
FONT-SIZE Plus   Neg

KalVista Pharmaceuticals Inc. (KALV) Closed Challenging The Highs Of The Year

KalVista Pharmaceuticals Inc. (KALV) announced Tuesday morning that it has entered into a collaboration agreement with Merck for KVD001.

KalVista Pharmaceuticals gapped open sharply higher Tuesday, but pared its gains throughout the first 2 hours of trade. Shares still finished up by 2.84 at $10.19 on the highest volume of the year. The stock closed challenging the highs of the year, trading at over a 10-month high.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT